A long-acting HIV jab promises near-perfect protection at just $40 a year, but 115 nations must wait for India's approval of ...

Drug can be used to prevent catching the virus and treat those who have it Kampala, Uganda | THE INDEPENDENT & AGENCIES | A ...

According to the World Health Organization (WHO), lenacapavir offers a highly effective, long-acting alternative to daily ...

A groundbreaking injectable drug, lenacapavir, offers renewed hope in the fight against HIV. Set to be available in 2027 in ...

Indian generic manufacturers will produce lenacapavir, a near 100% effective, six-month injectable HIV prevention drug, ...

Press Release - The U.S. Department of State announced a life-saving development to bring U.S.-based Gilead Sciences' breakthrough drug lenacapavir to market in Uganda, one of just ten high-burden HIV ...

Linda-Gail Bekker, who helped prove the drug Lenacapavir’s effectiveness, tells The Independent that $40 doses bring hope – ...

Uganda is among the 10 high-burden countries selected to benefit through the US President’s Emergency Plan for Aids Relief ...

Cheap generic versions of a groundbreaking HIV-prevention jab should be available in more than 100 countries from 2027, ...

A partnership will enable low-cost, generic lenacapavir for HIV prevention in LMICs, aiming to improve access and reduce infections significantly.

This antiretroviral has shown unprecedented results in HIV prevention, requiring only two injections per year. Its ...